The ability to modulate deep brain structures without surgery has long been a holy grail for neuroscience and sleep medicine. A wearable patch that can simultaneously target the subthalamic nucleus and read electrophysiological signals in real time challenges the assumption that meaningful deep-brain neuromodulation requires implanted electrodes — a significant shift in what non-invasive bioelectronics can achieve.
The device, called NEUSLeeP, integrates three functional components within a flexible, skin-conforming substrate: a tunable concentric-ring array for transcranial focused ultrasound, hydrogel-based electrophysiological electrodes, and compliant interconnects designed for overnight wear. In a 28-participant human trial, the system delivered spatially selective ultrasound stimulation targeting the subthalamic nucleus (STN) during natural sleep while concurrently recording neural activity. Participants showed a 4.6% increase in REM sleep duration and a 24% reduction in REM latency — meaning sleep cycles reached the REM stage substantially faster.
What distinguishes this work from prior ultrasound neuromodulation efforts is the closed-loop architecture: the patch doesn't just stimulate, it monitors electrophysiological response in real time, enabling adaptive modulation rather than fixed-protocol delivery. The STN choice is notable given its established roles in motor control, arousal regulation, and oscillatory neural dynamics — areas with therapeutic relevance well beyond sleep.
The 28-participant cohort is modest, and the magnitude of REM improvement, while statistically significant, requires replication in larger, more diverse samples before clinical implications can be drawn. It also remains unclear whether STN modulation is causal to the REM changes or whether ultrasound is influencing broader thalamocortical circuits. Nonetheless, publishing a registered clinical trial (NCT07190287) alongside hardware engineering in Nature Communications elevates this considerably above typical proof-of-concept bioelectronics work. If the platform scales, it could open non-invasive treatment pathways for REM sleep disorders, Parkinson's disease, and beyond.
